check_circleStudy Completed

Hypogonadism, Male

Bayer Identifier:

90481

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Study to assess safety and pharmacokinetics after repeated i.m. administration of 1000 mg Testosterone Undecanoate in hypogonadal male patients

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Trial summary

Enrollment Goal
26
Trial Dates
June 1999 - September 2004
Phase
Phase 2
Could I Receive a placebo
N/A
Products
Nebido (Testosterone Undeconate, BAY86-5037)
Accepts Healthy Volunteer
N/A

Primary Outcome

Secondary Outcome

Trial design

Open-label study to evaluate safety and pharmacokinetic parameters of total and free testosterone after repeated i.m. administration of 1000 mg testosterone undecanoate (5 injections over 36 weeks) in hypogonadal male patients
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.